Welcome to our dedicated page for Ventas news (Ticker: VTR), a resource for investors and traders seeking the latest updates and insights on Ventas stock.
Ventas, Inc. is an S&P 500 real estate investment trust with a healthcare and senior housing property portfolio in North America and the United Kingdom. News about VTR commonly covers quarterly results, senior housing operating portfolio performance, occupancy and RevPOR trends, net operating income, healthcare real estate investments, dividends and tax treatment of distributions.
Company updates also address investor presentations, earnings calls, capital allocation and portfolio categories that include senior housing communities, outpatient medical buildings, research centers and healthcare facilities.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Land & Buildings Investment Management has voiced dissatisfaction with Ventas (NYSE: VTR), expressing concerns over its ongoing underperformance and undervaluation. In a letter to the Board, they announced intentions to vote against Lead Independent Director James Shelton and Chair Debra Cafaro at the upcoming Annual Meeting on May 16, 2023. Notably, Ventas has underperformed against peer Welltower (NYSE: WELL), with a 26% discount in cash flow multiple and a 130 basis points higher cap rate. Furthermore, Ventas is projecting a decline in Funds from Operations (FFO) in 2023 while Welltower anticipates growth. Land & Buildings emphasizes the need for significant changes in leadership and strategy to enhance shareholder value.
Integral Molecular, a key player in Philadelphia's biotech sector, has officially opened its new 32,000 square foot headquarters, which includes pandemic preparedness laboratories. This expansion at One uCity marks significant growth for the company, which will double its headquarter footprint and accommodate 200 employees, adding 100 new technology jobs. The facility will enhance Integral Molecular's capabilities in R&D and manufacturing, crucial for addressing future viral threats. The opening event featured local leaders, including Philadelphia Mayor Jim Kenney. The company has been instrumental in providing vital reagents during the COVID-19 pandemic and continues to contribute to advancing therapeutics against various viral diseases.
Ventas, Inc. (NYSE: VTR) will release its first quarter 2023 earnings after trading closes on May 8, 2023. A conference call to discuss these earnings is scheduled for May 9, 2023, at 10:00 a.m. ET. Investors can join the call by dialing (888) 330-3576 or +1 (646) 960-0672 internationally, using passcode 7655497. A live webcast will be available on www.ventasreit.com.
A telephonic replay will be accessible at (800) 770-2030 for 30 days post-call. Ventas operates a diversified portfolio of over 1,200 properties across the U.S., Canada, and the UK, focusing on healthcare and real estate driven by an aging population.
Ventas, Inc. (NYSE: VTR) announced the pricing terms for its cash tender offers via Ventas Canada Finance Limited, aiming to purchase outstanding notes previously detailed on April 3, 2023. The maximum purchase price increased from Cdn$500 million to Cdn$600 million. The Offers will expire at 5:00 p.m. Toronto time on May 1, 2023. Holders of validly tendered notes by the Early Tender Time will receive accrued interest until the expected Early Settlement Date of April 24, 2023. Due to high demand, all 2.80% Senior Notes, Series E will be accepted, while 4.125% Senior Notes, Series B will face a proration factor of approximately 45.2%.
Ventas, Inc. (NYSE: VTR) has announced early tender results for its cash tender offers, initially disclosed on April 3, 2023. The company has increased the Maximum Aggregate Purchase Price from Cdn$500 million to Cdn$600 million. As of the Early Tender Time, approximately Cdn$718.9 million of notes were validly tendered. Key points include:
- Approximately Cdn$718.9 million in notes validly tendered
- Acceptance of all Priority Level 1 notes, with Level 2 notes prorated
- Eligible tendered notes to receive a Cdn$30 Early Tender Payment
- Deadline for withdrawal was April 19, 2023, with the offers expiring on May 1, 2023
Further details can be found in the Offer to Purchase disclosure.
Ardent Health Services has announced the appointment of two new senior operations leaders and the promotion of three executives. Mike Matthews is the new president of Ardent Physician Services, focusing on medical group operations across eight markets. David Schultz takes on the role of president for Ardent's New Mexico market, overseeing five hospitals and over 30 care sites. Additionally, Lisa Dolan has been promoted to senior vice president and chief nursing officer, enhancing quality and safety for over 7,000 nurses. Reed Smith will now serve as chief consumer officer, while Rebecca Kirkham has been named chief communications officer. The leadership changes aim to bolster patient engagement and advance value-based care networks.